FIELD: medicine.
SUBSTANCE: what is described is the FRWGPGP peptide possessing neurotropic properties.
EFFECT: extended range of neurotropic properties, the peptide used enables better animal training and improves their exploratory activity.
4 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE POSSESSING NEUROTROPIC PROPERTIES | 2011 |
|
RU2443711C1 |
| HEXAPEPTIDE ELICITING MEMORY STIMULATING ACTIVITY | 1998 |
|
RU2131743C1 |
| ANXIOLYTIC AGENT AND PHARMACEUTICAL COMPOSITION WITH ANXIOLYTIC EFFECT | 1999 |
|
RU2155065C1 |
| QUINAZOLINE DERIVATIVES, POSSESSING ANTIDEPRESSANT, ANXIOLYTIC AND NOOTROPIC ACTIVITY | 2012 |
|
RU2507199C1 |
| PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
| COMPOUNDS HAVING ANTI-ISCHEMIC, ANTIANGINAL, CYTOPROTECTIVE PROPERTIES, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF, A METHOD OF TREATING A NEURODEGENERATIVE DISEASE, A METHOD OF TREATING A PSYCHIC DISORDER | 2019 |
|
RU2741910C2 |
| 9-[2-(4-ISOPROPYLPHENOXY)ETHYL]ADENINE POSSESSING ANTIDEPRESSANT AND STRESS-RELIEVING ACTION | 2013 |
|
RU2529817C1 |
| PEPTIDE HAVING NEUROPROTECTIVE AND NOOTROPIC ACTIVITY AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2014 |
|
RU2557003C2 |
| MEDICATION POSSESSING ANTIDEPRESSIVE, ANXIOLYTIC AND NOOTROPIC ACTION | 2010 |
|
RU2437659C1 |
| METHOD OF PRODUCING BIOPREPARATION WITH NOOTROPIC ACTIVITY | 2015 |
|
RU2609872C1 |
Authors
Dates
2012-02-27—Published
2011-02-02—Filed